Codexis Provides Update on Prioritized Corporate Strategy

November 29, 2022

https://www.globenewswire.com/news-release/2022/11/29/2564491/24825/en/Codexis-Provides-Update-on-Prioritized-Corporate-Strategy.html

REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its time and resources on areas where the Company believes it has the strongest commercial opportunity and greatest probability of success. As part of this plan, the Company has decided to discontinue investment in certain internal development programs, expand investment in high potential development programs and reduce its workforce by approximately 18%.

Read more at globenewswire.com

Related news for (CDXS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.